These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23307753)

  • 1. The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions.
    Jantas D; Roman A; Kuśmierczyk J; Lorenc-Koci E; Konieczny J; Lenda T; Lasoń W
    Neurotox Res; 2013 Jul; 24(1):41-54. PubMed ID: 23307753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's disease.
    Konieczny J; Jantas D; Lenda T; Domin H; Czarnecka A; Kuter K; Śmiałowska M; Lasoń W; Lorenc-Koci E
    Neurotox Res; 2014 Oct; 26(3):255-73. PubMed ID: 24842651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
    Lopes FM; da Motta LL; De Bastiani MA; Pfaffenseller B; Aguiar BW; de Souza LF; Zanatta G; Vargas DM; Schönhofen P; Londero GF; de Medeiros LM; Freire VN; Dafre AL; Castro MA; Parsons RB; Klamt F
    Neurotox Res; 2017 May; 31(4):545-559. PubMed ID: 28155214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of mGluR II and III activators against staurosporine- and doxorubicin-induced cellular injury in SH-SY5Y cells: New evidence for a mechanism involving inhibition of AIF translocation.
    Jantas D; Greda A; Leskiewicz M; Grygier B; Pilc A; Lason W
    Neurochem Int; 2015 Sep; 88():124-37. PubMed ID: 25661514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celastrol from 'Thunder God Vine' protects SH-SY5Y cells through the preservation of mitochondrial function and inhibition of p38 MAPK in a rotenone model of Parkinson's disease.
    Choi BS; Kim H; Lee HJ; Sapkota K; Park SE; Kim S; Kim SJ
    Neurochem Res; 2014 Jan; 39(1):84-96. PubMed ID: 24214023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosmarinic Acid Attenuates Rotenone-Induced Neurotoxicity in SH-SY5Y Parkinson's Disease Cell Model through Abl Inhibition.
    Han X; Han B; Zhao Y; Li G; Wang T; He J; Du W; Cao X; Gan J; Wang Z; Zheng W
    Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line.
    Magalingam KB; Radhakrishnan AK; Somanath SD; Md S; Haleagrahara N
    Mol Biol Rep; 2020 Nov; 47(11):8775-8788. PubMed ID: 33098048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNJ-1945, a calpain inhibitor, protects SH-SY5Y cells against MPP(+) and rotenone.
    Knaryan VH; Samantaray S; Park S; Azuma M; Inoue J; Banik NL
    J Neurochem; 2014 Jul; 130(2):280-90. PubMed ID: 24341912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of polyphyllin VI against rotenone-induced toxicity in SH-SY5Y cells.
    Li L; Chen Z; Hao C
    Brain Res; 2024 May; 1830():148824. PubMed ID: 38417654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
    Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
    Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective and Neurite Outgrowth Stimulating Effects of New Low-Basicity 5-HT
    Jakubowska K; Hogendorf AS; Gołda S; Jantas D
    Neurochem Res; 2024 Aug; 49(8):2179-2196. PubMed ID: 38834845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
    Imamura K; Takeshima T; Kashiwaya Y; Nakaso K; Nakashima K
    J Neurosci Res; 2006 Nov; 84(6):1376-84. PubMed ID: 16917840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human platelet lysate supports SH-SY5Y neuroblastoma cell proliferation and differentiation into a dopaminergic-like neuronal phenotype under xenogeneic-free culture conditions.
    Ribeiro M; Campos J; Pinho TS; Sampaio-Marques B; Barata-Antunes S; Cibrão JR; Araújo R; Duarte-Silva S; Moreira E; Sousa RA; Costa PM; Salgado AJ
    Biotechnol J; 2024 Jul; 19(7):e2400068. PubMed ID: 38987218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the extract of Anemopaegma mirandum (Catuaba) on Rotenone-induced apoptosis in human neuroblastomas SH-SY5Y cells.
    Valverde G De Andrade D; Madureira de Oliveria D; Barreto G; Bertolino LA; Saraceno E; Capani F; Giraldez LD
    Brain Res; 2008 Mar; 1198():188-96. PubMed ID: 18241847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
    Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
    Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells.
    Jaworska-Feil L; Jantas D; Leskiewicz M; Budziszewska B; Kubera M; Basta-Kaim A; Lipkowski AW; Lason W
    Neuropeptides; 2010 Dec; 44(6):495-508. PubMed ID: 20869113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fraxetin and myricetin on rotenone-induced cytotoxicity in SH-SY5Y cells: comparison with N-acetylcysteine.
    Molina-Jimenez MF; Sanchez-Reus MI; Benedi J
    Eur J Pharmacol; 2003 Jul; 472(1-2):81-7. PubMed ID: 12860476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impairments of α-Synuclein and Mechanistic Target of Rapamycin in Rotenone-Induced SH-SY5Y Cells and Mice Model of Parkinson's Disease.
    Ramalingam M; Huh YJ; Lee YI
    Front Neurosci; 2019; 13():1028. PubMed ID: 31611767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists.
    Presgraves SP; Ahmed T; Borwege S; Joyce JN
    Neurotox Res; 2004; 5(8):579-98. PubMed ID: 15111235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective potential of traditionally used medicinal plants of Manipur against rotenone-induced neurotoxicity in SH-SY5Y neuroblastoma cells.
    Hijam AC; Tongbram YC; Nongthombam PD; Meitei HN; Koijam AS; Rajashekar Y; Haobam R
    J Ethnopharmacol; 2024 Aug; 330():118197. PubMed ID: 38636579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.